GSK3-Mediated BCL-3 Phosphorylation Modulates Its Degradation and Its Oncogenicity
- 1 October 2004
- journal article
- research article
- Published by Elsevier BV in Molecular Cell
- Vol. 16 (1), 35-45
- https://doi.org/10.1016/j.molcel.2004.09.004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cytoplasmic IκBα Increases NF-κB-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3Published by Elsevier BV ,2003
- NF-κB2/p100 induces Bcl-2 expressionLeukemia, 2003
- Regulating the RegulatorsCell, 2003
- Bcl‐3 is an interleukin‐1–responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 geneArthritis & Rheumatism, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell TransitionJournal of Biological Chemistry, 2001
- IκB-α Enhances Transactivation by the HOXB7 Homeodomain-containing ProteinPublished by Elsevier BV ,1999
- Diverse Effects of BCL3 Phosphorylation on Its Modulation of NF-κB p52 Homodimer Binding to DNAJournal of Biological Chemistry, 1997
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993